| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| ACCOUNTING FEES | 4,080 | 0 | 4,080 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| TD AMERITRADE - EVOK PHARMA INC | 120,000 | 5,500 |
| TD AMERITRADE - NEPHROGENIX INC | 180,000 | 0 |
| TD AMERITRADE - HEAT BIOLOGICS | 1,430,170 | 15,103 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| QMS DIVERSIFIED GLOBAL MACRO US FUND LP | AT COST | 1,222,379 | 1,222,379 |
| Description | Beginning of Year - Book Value | End of Year - Book Value | End of Year - Fair Market Value |
|---|---|---|---|
| ORGANIZATION COSTS | 0 | 0 | 0 |
| Description | Amount |
|---|---|
| PRIOR PERIOD ADJUSTMENT | 400 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| BANK SERVICE CHARGES | 121 | 0 | 0 | |
| OFFICE EXPENSES | 231 | 0 | 0 |
| Description | Revenue And Expenses Per Books | Net Investment Income | Adjusted Net Income |
|---|---|---|---|
| QMS DIVERSIFIED GLOBAL MARCO US FUND LP - ORDINARY LOSS | -16,256 | -16,256 | -16,256 |
| QMS DIVERSIFIED GLOBAL MACRO US FUND LP - NET SECTION 1256 GAIN FROM TRADING | 198,935 | 198,935 | 198,935 |
| QMS DIVERSIFIED GLOBAL MACRO US FUND LP - NET SECTION 988 LOSS FROM TRADING | -187,333 | -187,333 | -187,333 |
| QMS DIVERSIFIED GLOBAL MACRO US FUND LP - SHORT TERM CAPITAL GAIN | 67,460 | 67,460 | 67,460 |
| QMS DIVERSIFIED GLOBAL MACRO US FUND LP - LONG-TERM CAPITAL LOSS | -6,168 | -6,168 | -6,168 |